Formulation and Delivery

Formulation and delivery strategy plays an increasingly critical role in drug development success. Today, the pursuit of increasingly complex and difficult to solubilize compounds, and extending therapeutic franchise value, places escalating demands for new and better formulation and delivery technologies and strategies. As companies globally increasingly enter the formulation and delivery space, elevating both innovation and competition, choice of technology platform and partners is fast becoming a strategic issue impacting both drug development and corporate development success.

Companies looking for the future in formulation and delivery technologies must:
  • Grasp what is driving the consumer preference driven technology evolution
  • Look for the early opportunities in R&D to drive improvements in product development
  • Evaluate how wise use of formulation and delivery technologies can both extend existing franchise value and create new opportunities
  • Understand how advances in formulation and delivery technologies create opportunities to enter into adjacent industries such as cosmetics, nutrition, and devices
  • See the convergence of materials and manufacturing that creates disruptive opportunities in healthcare

Sample topics covered by Lux Research:

Technologies:

Formulation Technologies

  • Encapsulation
  • Carriers
  • Bio-chemical targeting
  • Nano/Micro-nisation
  • Lipid formulations
  • Template production
  • Solid/Amorphous states
  • Adsorption enhancers
  • Adhesive excipients
  • Biologic excipients
  • Dendrimers
  • Halloysite/ Carbon nanotubes

Delivery Devices

  • Micro-needles
  • Inhalers
  • Intranasal spray
  • Occular implants
  • Photodynamic nanoparticles
  • Electronically-enabled devices
  • Absorbable stents
  • Iontophoretic delivery

Key Issues:

  • Product/Drug Development
  • Managing Product Lifecycle
  • Pipeline Revival
  • Product Repositioning
  • Attacking market adjacencies
  • Company evaluation
  • Market trends/ sizing
  • Assessing the state of newcomers
  • Investment, partnership, and acquisition opportunities
  • Regulatory issues; drivers and constraints

Companies:

  • Fertin Pharma
  • AddBio
  • SurModics
  • Galenix
  • Chrono Therapeutics
  • Vectura
  • Emisphere Technologies
  • ERYtech Pharma
  • Amplyx
  • Aquea Scientific
  • Vive Nano
  • MagForce Nanotechnologies
  • Elan
  • MonoSol Rx
  • Broda Technologies
  • CoSci Med-Tech
  • Promed Medical Tech
  • View a sample Company Profile